Lava Therapeutics B.V.
Jessica Truscello has been working in the clinical operations field since 1999. Jessica started their career at Covance as a Clinical Research Associate (CRA), a role they held for two years. In 2002, they moved to Wyeth where they were a Clinical Trial Leader. In 2010, they joined Pfizer as a Director, Asset Operations Lead, and then a Clinical Program Manager. In 2015, they joined Immunocore as Vice President, Head of Clinical Operations, and then Senior Director, Head of Clinical Operations. In 2021, they moved to LAVA Therapeutics N.V. as Vice President Clinical Operations.
Jessica Truscello received their Bachelor of Science (B.S.) in Comprehensive Science from Villanova University in 1999, having started their studies there in 1995.
This person is not in any offices
Lava Therapeutics B.V.
Lava Therapeutics is focused on applying its expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy.